Estimating the Impact of Adding C-Reactive Protein as a Criterion for Lipid Lowering Treatment in the United States
Clinical guideline published by National Heart, Lung, and Blood Institute (NHLBI) on
The National Heart, Lung, and Blood Institute (NHLBI) leads research, training, and education initiatives aimed at preventing and treating heart, lung, and blood disorders. Its mission is to enhance health and promote longer, fulfilling lives through innovative research and public education.